REDCLOUD HOLDINGS PLC (RCT) Fundamental Analysis & Valuation

NASDAQ:RCT • GB00BMCD0001

Current stock price

0.675 USD
-0.04 (-6.09%)
At close:
0.6751 USD
+0 (+0.01%)
After Hours:

This RCT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. RCT Profitability Analysis

1.1 Basic Checks

  • In the past year RCT has reported negative net income.
  • RCT had a negative operating cash flow in the past year.
RCT Yearly Net Income VS EBIT VS OCF VS FCFRCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • With a Return On Assets value of -576.40%, RCT is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -576.4%
ROE N/A
ROIC N/A
ROA(3y)-313.11%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RCT Yearly ROA, ROE, ROICRCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 -100 -200 -300 -400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for RCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RCT Yearly Profit, Operating, Gross MarginsRCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -100 -200 -300 -400 -500

0

2. RCT Health Analysis

2.1 Basic Checks

  • RCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for RCT remains at a similar level compared to 1 year ago.
  • RCT has a worse debt/assets ratio than last year.
RCT Yearly Shares OutstandingRCT Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M
RCT Yearly Total Debt VS Total AssetsRCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -26.94, we must say that RCT is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -26.94, RCT is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -26.94
ROIC/WACCN/A
WACC6.4%
RCT Yearly LT Debt VS Equity VS FCFRCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M -20M -40M -60M

2.3 Liquidity

  • A Current Ratio of 0.27 indicates that RCT may have some problems paying its short term obligations.
  • With a Current ratio value of 0.27, RCT is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
  • RCT has a Quick Ratio of 0.27. This is a bad value and indicates that RCT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of RCT (0.27) is worse than 86.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
RCT Yearly Current Assets VS Current LiabilitesRCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M

4

3. RCT Growth Analysis

3.1 Past

  • RCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.48%.
  • The Revenue has grown by 79.68% in the past year. This is a very strong growth!
EPS 1Y (TTM)-48.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.49%
Revenue 1Y (TTM)79.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.81%

3.2 Future

  • Based on estimates for the next years, RCT will show a very strong growth in Earnings Per Share. The EPS will grow by 41.27% on average per year.
  • RCT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 49.98% yearly.
EPS Next Y29.1%
EPS Next 2Y41.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.02%
Revenue Next 2Y49.98%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

RCT Yearly Revenue VS EstimatesRCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
RCT Yearly EPS VS EstimatesRCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.2 -0.4 -0.6 -0.8

1

4. RCT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RCT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RCT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RCT Price Earnings VS Forward Price EarningsRCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RCT Per share dataRCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

  • RCT's earnings are expected to grow with 41.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.27%
EPS Next 3YN/A

0

5. RCT Dividend Analysis

5.1 Amount

  • No dividends for RCT!.
Industry RankSector Rank
Dividend Yield 0%

RCT Fundamentals: All Metrics, Ratios and Statistics

REDCLOUD HOLDINGS PLC

NASDAQ:RCT (4/2/2026, 8:00:01 PM)

After market: 0.6751 +0 (+0.01%)

0.675

-0.04 (-6.09%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)12-11
Earnings (Next)N/A
Inst Owners2.6%
Inst Owner ChangeN/A
Ins Owners77.62%
Ins Owner Change0%
Market Cap37.34M
Revenue(TTM)64.47M
Net Income(TTM)-77.26M
Analysts80
Price Target5.95 (781.48%)
Short Float %0.83%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)12.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-235.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.89
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS1.17
BVpS-0.14
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -576.4%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-313.11%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover4.81
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 204.37%
Cap/Sales 7.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z -26.94
F-Score6
WACC6.4%
ROIC/WACCN/A
Cap/Depr(3y)133.19%
Cap/Depr(5y)N/A
Cap/Sales(3y)13.34%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.49%
EPS Next Y29.1%
EPS Next 2Y41.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)79.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.81%
Revenue Next Year18.02%
Revenue Next 2Y49.98%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-62.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.64%
OCF growth 3YN/A
OCF growth 5YN/A

REDCLOUD HOLDINGS PLC / RCT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of REDCLOUD HOLDINGS PLC (RCT) stock?

ChartMill assigns a fundamental rating of 1 / 10 to RCT.


Can you provide the valuation status for REDCLOUD HOLDINGS PLC?

ChartMill assigns a valuation rating of 1 / 10 to REDCLOUD HOLDINGS PLC (RCT). This can be considered as Overvalued.


Can you provide the profitability details for REDCLOUD HOLDINGS PLC?

REDCLOUD HOLDINGS PLC (RCT) has a profitability rating of 0 / 10.


What is the financial health of REDCLOUD HOLDINGS PLC (RCT) stock?

The financial health rating of REDCLOUD HOLDINGS PLC (RCT) is 0 / 10.